- Previous Close
40.81 - Open
40.25 - Bid 39.77 x 400
- Ask 40.56 x 400
- Day's Range
39.11 - 41.13 - 52 Week Range
28.16 - 60.12 - Volume
320,037 - Avg. Volume
618,230 - Market Cap (intraday)
1.157B - Beta (5Y Monthly) 0.95
- PE Ratio (TTM)
-- - EPS (TTM)
-3.00 - Earnings Date May 6, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
55.57
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells its products to physicians, hospitals, and clinics through distributors and its direct sales force in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
www.establishmentlabs.comRecent News: ESTA
View MorePerformance Overview: ESTA
Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ESTA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ESTA
View MoreValuation Measures
Market Cap
1.18B
Enterprise Value
1.31B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.93
Price/Book (mrq)
22.19
Enterprise Value/Revenue
7.91
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-50.95%
Return on Assets (ttm)
-10.15%
Return on Equity (ttm)
-236.66%
Revenue (ttm)
166.02M
Net Income Avi to Common (ttm)
-84.6M
Diluted EPS (ttm)
-3.00
Balance Sheet and Cash Flow
Total Cash (mrq)
90.35M
Total Debt/Equity (mrq)
424.32%
Levered Free Cash Flow (ttm)
-37.94M